CCL2 and pulmonary fibrosis: Some studies have found that FCGR3B can lead to pulmonary fibrosis through proinflammatory and fibrogenic processes, including tumor necrosis factor-α, transforming growth factor-β, MCP-1, and IL-8 [49].